Before submitting a signed declaration of interests (‘DOI’) to the Commission and until the Commission has assessed the declared interests in accordance with Article 4, the representatives appointed to the Coordination Group and its subgroups referred to in Article 5(3) of Regulation (EU) 2021/2282 (‘representatives’) may not do any of the following:
access the parts of the secure system of the IT platform, as defined in Article 30 of Regulation (EU) 2021/2282 (‘the HTA IT platform’) relevant for the performance of their tasks;
take up the roles and responsibilities of a chair or a co-chair in the Coordination Group or its subgroups;
take up the roles and responsibilities of an assessor or a co-assessor for a joint clinical assessment or a joint scientific consultation;
attend meetings of the Coordination Group or its subgroups for conducting joint clinical assessments, joint scientific consultations, developing methodological guidance for joint work or for preparing reports on emerging health technologies.
Before submitting a signed declaration of interests (‘DOI’) to the Commission and until the Commission has assessed the declared interest in accordance with Article 4, patients, clinical experts and other relevant experts referred to in Article 5(5) of Regulation (EU) 2021/2282 (‘individual experts’) may not be selected and take part in a joint clinical assessment or a joint scientific consultation and may not access the parts of the secure system of the HTA IT platform relevant for the performance of their tasks.